Drug for rare form of ALS, based in part on WashU research, approved by FDA
Drug for rare form of ALS, based in part on WashU research, approved by FDA A new drug has been approved by the Food and Drug Administration (FDA) for a rare, inherited form of amyotrophic lateral sclerosis (ALS). Called tofersen, the drug — developed by Biogen Inc. and based in part